Ursodeoxycholic acid and severe COVID-19 outcomes in people with liver disease: a cohort study using the OpenSAFELY platform

Ruth E Costello, Karen Maree Jean Waller, Rachel Smith, George F Mells, Angel YS Wong, Anna Schultze, Viyaasan Mahalingasivam, Emily Herrett, Bang Zheng, Liang-Yu Lin, Amir Mehrkar, Sebastian CJ Bacon, Ben Goldacre, Laurie A Tomlinson, John Tazare, Christopher T Rentsch, the OpenSAFELY collaborative and the LH&W NCS (or CONVALESCENCE) Collaborative
doi: https://doi.org/10.1101/2023.12.11.23299191

Article usage

Article usage: December 2023 to November 2024

AbstractFullPdf
Dec 2023327865
Jan 202439722
Feb 202445416
Mar 202426620
Apr 202432720
May 202431320
Jun 202428111
Jul 202426414
Aug 202430420
Sep 202434314
Oct 202412813
Nov 202423312
Back to top
Posted December 13, 2023.
Download PDF
Data/Code
Email
Ursodeoxycholic acid and severe COVID-19 outcomes in people with liver disease: a cohort study using the OpenSAFELY platform
Ruth E Costello, Karen Maree Jean Waller, Rachel Smith, George F Mells, Angel YS Wong, Anna Schultze, Viyaasan Mahalingasivam, Emily Herrett, Bang Zheng, Liang-Yu Lin, Amir Mehrkar, Sebastian CJ Bacon, Ben Goldacre, Laurie A Tomlinson, John Tazare, Christopher T Rentsch, the OpenSAFELY collaborative and the LH&W NCS (or CONVALESCENCE) Collaborative
medRxiv 2023.12.11.23299191; doi: https://doi.org/10.1101/2023.12.11.23299191
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area